SFTPD and familial pancreatic carcinoma: In this study, we report, for the first time, a novel anti-EMT role of human SP-D, which interferes with TGF-β induced EMT by blocking Smad phosphorylation, using pancreatic cancer cell lines, Panc-1, and MiaPaCa-2, and Capan-2.